Bioperfectus Measles and Rubella Viruses Real-Time PCR Kit: What Labs Should Verify

Measles and Rubella Viruses Real-Time PCR Kit

The Bioperfectus Measles and Rubella Viruses Real-Time PCR Kit is listed for molecular diagnostic testing related to measles and rubella viruses. Its stated configuration covers the N gene of measles virus, the E1 gene of rubella virus, and RNaseP as an internal control.

The product page identifies throat swabs as the sample type and a 5μL sample input volume. It reports limit of detection values of 10 TCID50/mL for measles and 20 TCID50/mL for rubella, alongside clinical sensitivity and specificity figures. These are supplier-stated specifications that a laboratory should confirm against its own validation and intended use.

The kit is supplied as 50 tests per kit under catalogue MD112302C00201-50T. That package size matters for low-throughput surveillance labs, outbreak response stockpiles, and sites balancing reagent expiry against expected case volumes.

Use is restricted to trained personnel following the instructions for use, laboratory procedures, and local regulatory requirements. The product page identifies IVDR status, so procurement teams should request the relevant declaration, IFU version, and labelling details before purchase.

Buyers should verify extraction platform compatibility, PCR instrument requirements, transport conditions, and shelf life directly with the supplier. Scientific China lists support for sourcing, configuration, MOQ, and logistics, but those commercial terms should be documented in a formal quotation.

Why it matters:
For diagnostic procurement, the decisive checks are regulatory documentation, sample-type fit, performance evidence, and lot logistics—because a PCR kit is only useful if it integrates with the lab’s validated workflow.

View Product →